SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-17-009110
Filing Date
2017-02-14
Accepted
2017-02-14 13:07:26
Documents
1
Group Members
VENROCK ASSOCIATES VI, L.P.VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.VENROCK MANAGEMENT VI, LLCVENROCK PARTNERS MANAGEMENT VI, LLCVENROCK PARTNERS VI, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT II, LLCVHCP MAN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-4343_1sc13ga.htm SC 13G/A 381624
  Complete submission text file 0001104659-17-009110.txt   383718
Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650-475-3734
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Subject) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88402 | Film No.: 17606201
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences